Skip to main content

ADAP Advocacy Airs Digital Commercial Highlighting the Promise Behind the 340B Drug Pricing Program and Why Patients Favor Reform

ⓘ This article is third-party content and does not represent the views of this site. We make no guarantees regarding its accuracy or completeness.




Commercial: "The Glue That Should Hold Our Healthcare System Together"

WASHINGTON, DC, October 01, 2026 /24-7PressRelease/ -- ADAP Advocacy today, as part of its 340B Project, released a new digital commercial about the 340B Drug Pricing Program. The commercial reinforces the central message of the policy paper the organization published earlier this year under the same name, "340B PROGRAM: The Glue That Should Hold Our Healthcare System Together."

Few areas in the healthcare ecosystem aren't, in one way or another, impacted by the 340B Program—including as the backbone for certain services and healthcare providers nationwide, such as HIV. For that reason, a healthcare program of this size, magnitude, and importance cannot be entrusted to good faith alone; rather, improved accountability and transparency guardrails are needed to ensure its success and ultimately its intended beneficiaries: patients.

Brandon M. Macsata, CEO of ADAP Advocacy, summarized: "The debate surrounding whether to reform the 340B Program has largely been settled, thanks to the growing chorus recognizing the program isn't living up to the legislative intent. For patients, it is failing to deliver on its promise of expanding affordable healthcare, as shown by the growing medical debt crisis in this country, much of it owed to hospitals. Our new digital commercial moves the debate forward as Congress debates 340B legislation."

The commercial will air across numerous digital and social platforms. The commercial continues ADAP Advocacy's '340B Too Big To Fail' national advocacy campaign, highlighting hospitals' declining charity, rising healthcare executive compensation, and exploding patient medical debt, among other issues.

The commercial is available online at https://tinyurl.com/bdea39d2.

To learn more about ADAP Advocacy, the 340B Drug Pricing Program, or the new 340B commercial, please email info@adapadvocacy.org.

ADAP Advocacy's mission is to promote and enhance the AIDS Drug Assistance Programs (ADAPs) and improve access to care for persons living with HIV/AIDS. ADAP Advocacy works with advocates, community members, health care providers, government officials, patients, pharmaceutical companies, and other stakeholders to raise awareness, offer patient education programs, and foster greater community collaboration.

---
Press release service and press release distribution provided by https://www.24-7pressrelease.com
Report this content

If you believe this article contains misleading, harmful, or spam content, please let us know.

Report this article

Recent Quotes

View More
Symbol Price Change (%)
AMZN  247.49
-1.66 (-0.67%)
AAPL  328.07
-4.95 (-1.49%)
AMD  612.22
+0.46 (0.08%)
BAC  53.70
-0.73 (-1.33%)
GOOG  334.65
-6.09 (-1.79%)
META  727.88
+2.70 (0.37%)
MSFT  513.57
+0.67 (0.13%)
NVDA  230.88
+2.50 (1.10%)
ORCL  137.28
-0.02 (-0.01%)
TSLA  355.75
+0.94 (0.26%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.